Sep 29, 2022 | False Claims Act, Government Investigations, Health Care Fraud
On September 26, 2022, the Department of Justice (DOJ) announced that pharmaceutical giant Biogen, Inc. agreed to pay $900 million to resolve allegations that it violated the False Claims Act (FCA) by paying prescribing physicians kickbacks in exchange for prescribing...
Sep 19, 2022 | False Claims Act
The False Claims Act (“FCA”) continues to be a significant tool for the government to ensure compliance with companies that contract with the United States. The FCA prohibits any person from knowingly presenting, or causing to be presented, a false or fraudulent...
Sep 7, 2022 | False Claims Act
The Eleventh Circuit agreed with a Florida district court’s ruling that an employee needs “at least an objectively reasonable belief” that they engaged in protected conduct to recover for retaliation under the False Claims Act (FCA), and the FCA does not cover general...
Aug 24, 2022 | False Claims Act
The Department of Justice just announced that Universal Helicopters Inc. (UHI) and Dodge City Community College (DC3) have agreed to pay $7.5 million to resolve allegations of violating the False Claims Act (FCA). It was alleged that UHI and DC3 falsely certified...
Aug 8, 2022 | False Claims Act, Government Investigations
Biogen IDEC, Inc., a Cambridge, Massachusetts-based pharmaceutical company, agreed to pay $900 million to resolve alleged violations of the federal Anti-Kickback Statute (AKS) and False Claims Act (FCA). The agreement was made days before the trial – which was...
Aug 3, 2022 | False Claims Act
On July 22, 2022, the U.S. Department of Justice (DOJ) issued a press release noting that Biotronik Inc. greed to pay $12.95 million to resolve allegations it violated the False Claims Act and the Anti-Kickback Statute. The federal False Claims Act (“FCA”) and the...
